A phase 2 liver trial where the add-on drug didn't help — and the base drug quietly did
Read the Sunday Brief →

Study wrapper · #238

A method for confirming CJC-1295 abuse in equine plasma samples by LC-MS/MS.

Timms M, Ganio K, Steel R Drug testing and analysis. 2019.
Weak / noneOtherMentions: CJC-1295

Editor's note

This is an anti-doping detection study in horses, though its background usefully restates CJC-1295's defining pharmacology. The abstract notes that CJC-1295 carries a maleimido group letting it covalently bind blood proteins such as albumin, which greatly extends its half-life; the abstract states it can stimulate GH production for more than six days in humans after a single dose. The study itself, however, is analytical: the researchers confirmed CJC-1295 in equine plasma by LC-MS/MS after immuno-affinity capture and tryptic digestion, detecting it down to 180 pg/mL. The conjugated form is hard to catch because it is low-abundance, high-molecular-weight, and bound to varied proteins. For readers, the relevant points are the reported long duration of action (a background claim, not tested here) and that CJC-1295 is detectable in doping control. This is method-development work, not efficacy or safety evidence for CJC-1295.

Plain-language abstract

This study developed a way to confirm the peptide CJC-1295 in horse blood for drug-testing purposes. By way of background, the authors explain that CJC-1295 stimulates the pituitary gland to release growth hormone, and that it carries a chemical group letting it permanently attach to blood proteins such as albumin. This attachment greatly lengthens how long it lasts in the body; according to the abstract, it can stimulate growth-hormone production for more than six days in humans after a single dose. That same protein attachment makes the drug hard to detect, because it becomes bulky, scarce, and bound to a variety of proteins. To solve this, the researchers used an antibody-based capture step followed by enzyme digestion, then measured the fragments with a mass spectrometer (LC-MS/MS). The method identified CJC-1295 in horse blood at concentrations as low as 180 trillionths of a gram per millilitre. The study is about detecting CJC-1295 in horses; it does not test its effects or safety.